INTANGIBLE ASSET |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| INTANGIBLE ASSET | |
| INTANGIBLE ASSET | NOTE 9 – INTANGIBLE ASSET
The Company capitalized the costs associated with acquiring the exclusive worldwide license to develop and commercialize products comprising or containing the compound ART27.13 as an intangible asset at a value of $2,039 as of December 31, 2025, and 2024.
The amount capitalized consisted of a $1,500 payment and the fair value of 227 shares of common stock of $539. During the year ended December 31, 2025, no additional costs met the criteria for capitalization as an intangible asset. |